Calton & Associates, Inc. Guardant Health, Inc. Transaction History

Calton & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$20.94 - $38.01 $117,201 - $212,741	5,597 New	5,597 $200,000
Q4 2021 Jan 13, 2022	SELL	$88.71 - $120.43 $170,411 - $231,346	-1,921 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$98.77 - $132.17 $20,445 - $27,359	207 Added 12.08%	1,921 $240,000
Q2 2021 Aug 11, 2021	SELL	$109.77 - $165.68 $6,476 - $9,775	-59 Reduced 3.33%	1,714 $213,000
Q1 2021 May 03, 2021	SELL	$127.04 - $179.1 $1,270 - $1,791	-10 Reduced 0.56%	1,773 $271,000
Q4 2020 Jan 25, 2021	SELL	$99.96 - $135.93 $1,999 - $2,718	-20 Reduced 1.11%	1,783 $230,000
Q3 2020 Oct 30, 2020	BUY	$80.32 - $111.8 $144,816 - $201,575	1,803 New	1,803 $202,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.